Only 3% of people have heard of Lynch syndrome

• March 22, 2023
• The Eve Appeal

Our recent survey found that less than 3% of people had heard of Lynch syndrome.

Behind the headlines: New BRCA gene alteration variant found in Orkney

• March 18, 2023
• The Eve Appeal

We blog about yesterday’s news about a new founder population of a BRCA gene alteration in Orkney

I thought that ovarian cancer only occurred in older women

• March 11, 2023
• Jess

This OCAM, Jess shares her story of being diagnosed with a rare form of ovarian cancer

RCOG and women’s health organisations joint statement on stigma and shame in women’s health services

• March 8, 2023
• The Eve Appeal

First Rare Gynae Cancer Fund project announced in mucinous ovarian cancer

• March 1, 2023
• The Eve Appeal

We are delighted to announce our first Rare Gynae Cancer Fund project, in mucinous ovarian cancer.

Research News: we now understand more about HPV

• February 22, 2023
• Dr Chiara Herzog

Dr Chiara Herzog blogs about recent research which explored why some people clear HPV and some do not.

Urgent referrals for gynae cancer HALVED during the first wave of Covid 

• February 17, 2023
• The Eve Appeal

First data published on the impact of the covid pandemic on gynaecological cancer services.

You Need To Know

• January 31, 2023
• The Eve Appeal

Community campaign shines spotlight on one of north east London’s most common cancer types

New research shows a new technique can be used to give an immediate diagnosis for womb cancer

• January 4, 2023
• Sarah Graham

Research shows a new technique can be used to give an immediate diagnosis for womb cancer, Sarah Graham blogs.

Best Laid Plans Laid to Rest- Fenella’s story

• November 16, 2022
• Fenella Symes

Fenella updates us on where she is at after her results are back from genetic testing.

‘There are lots of lessons to be learned about hysteroscopy’

• November 4, 2022
• The Eve Appeal

Charlotte shared her experience of hysteroscopy and we blog about the lessons that need to be learned from what happened

Regular monitoring for ovarian cancer has been shown to be beneficial in women with BRCA gene alterations

• November 2, 2022
• The Eve Appeal

Research shows that surveillance of women at high risk of ovarian cancer would provide benefit.